CDK9-CyclinT1 PPI-IN-1 is a selective inhibitor of the CDK9-CyclinT1 protein-protein interaction (PPI); it inhibits the proliferation of TNBC MDA-MB-231 cells (IC50: 0.044 μM), induces apoptosis, suppresses CDK9 transcriptional activity, reduces phosphorylation of RNA Pol II CTD at Ser2, and inhibits tumor growth in a TNBC 4T1 xenograft mouse model.